Digitoxin activates EGR1 and synergizes with paclitaxel on human breast cancer cells

BACKGROUND: Numerous studies have suggested that digitalis derivatives promise to be superior to existing adjuvant therapy for breast cancer as to effects and side-effects. In the present study, we have used gene expression analysis to determine the molecular action of digitoxin on breast cancer cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Einbond, Linda Saxe, Wu, Hsan-au, Su, Tao, Chang, Tangel, Panjikaran, Maya, Wang, Xiaomei, Goldsberry, Sarah
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997271/
https://www.ncbi.nlm.nih.gov/pubmed/21139994
http://dx.doi.org/10.4103/1477-3163.72578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997271/
https://www.ncbi.nlm.nih.gov/pubmed/21139994
http://dx.doi.org/10.4103/1477-3163.72578

Ejemplares similares